O'Keeffe Charles B 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Nov 25, 2024
Insider Transaction Report
Form 4
O'Keeffe Charles B
Director
Transactions
- Award
Options to purchase common stock
2024-11-21+23,248→ 252,179 totalExercise: $21.12Exp: 2031-11-21→ Common Stock (23,248 underlying) - Award
Restricted stock units
2024-11-21+2,841→ 255,020 total→ Common Stock (2,841 underlying)
Footnotes (3)
- [F1]Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026 and 1/3rd on November 21, 2027.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F3]Shares of common stock will be delivered to the Reporting Person upon vesting.